Morphosys Ag ADR (MOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -159,155 | -483,967 | -380,602 | -137,639 | -608,658 |
| Depreciation Amortization | 11,100 | 7,900 | 5,473 | 2,886 | 11,939 |
| Accounts receivable | -19,139 | -14,662 | -44,654 | 2,691 | 12,461 |
| Accounts payable and accrued liabilities | -22,224 | -2,941 | -36,721 | -50,599 | -107,444 |
| Other Working Capital | -54,192 | -37,408 | -90,057 | -67,067 | -210,123 |
| Other Operating Activity | -142,751 | 269,489 | 293,273 | 88,342 | 332,227 |
| Operating Cash Flow | $-386,361 | $-261,588 | $-253,289 | $-161,386 | $-569,598 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 224 | -892,165 | 226 | N/A | 3,062,431 |
| PPE Investments | -2,036 | -1,237 | -1,092 | -656 | -4,508 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -1,427,540 |
| Purchase Of Investment | -1,985,885 | N/A | -602,337 | -230,051 | N/A |
| Sale Of Investment | 2,360,750 | 1,173,348 | 834,525 | 360,294 | 1,475,269 |
| Purchase Sale Intangibles | -14,009 | -8,397 | -3,928 | -657 | -26,438 |
| Other Investing Activity | -9,557 | -7,425 | -3,578 | -323 | -4,088,820 |
| Investing Cash Flow | $363,496 | $272,521 | $227,744 | $129,263 | $-983,168 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 25,049 | 19,643 | 20,755 | 16,830 | -942 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 100,244 |
| Other Financing Activity | 303,061 | 291,613 | -4,028 | -1,373 | 1,465,849 |
| Financing Cash Flow | $328,110 | $311,257 | $16,727 | $15,457 | $1,565,151 |
| Exchange Rate Effect | -11,182 | 14,106 | 4,355 | 534 | 3,532 |
| Beginning Cash Position | 129,854 | 124,136 | 131,161 | 138,309 | 129,898 |
| End Cash Position | 423,917 | 460,432 | 126,698 | 122,178 | 145,815 |
| Net Cash Flow | $294,063 | $336,296 | $-4,463 | $-16,132 | $15,917 |
| Free Cash Flow | |||||
| Operating Cash Flow | -386,361 | -261,588 | -253,289 | -161,386 | -569,598 |
| Capital Expenditure | -2,036 | -1,237 | -1,092 | -656 | -4,508 |
| Free Cash Flow | -388,397 | -262,825 | -254,381 | -162,042 | -574,106 |